FundedIQ

Recently Funded Post-IPO Equity Startups in the United States

Updated Aug 2026

FundedIQ holds 292 funded Post-IPO Equity startups in the United States (US) and keeps their funding rounds, amounts, investors, industries, locations and company details up to date. This page provides an overview of the Post-IPO Equity startup funding landscape in the United States, along with the 100 most recently funded Post-IPO Equity startups in the United States.

Biotechnology, Consumer Electronics and Health Care hold the most companies by sector. New York and Cambridge hold the deepest concentrations of these companies.

Public equity funding concentrates in New York and Cambridge. While the label implies late stage maturity, the sub-sectors include specialized biotech and healthcare firms. This mix creates a disparity in company size. Filtering by headcount distinguishes established corporate entities from leaner research outfits, which prevents a broad search from blending pharmaceutical giants with small laboratory teams.

Post-IPO Equity funded startup statistics in the United States

Funded Post-IPO Equity startups in the United States
292
tracked in the database

Most recent funding round on record: Oct 2022.

100 most recently funded Post-IPO Equity startups in the United States

100 of 292

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

V
Foster City, United States · Biotechnology
Vaxcyte, formerly known as SutroVax, is a next-generation vaccine company seeking to improve global health by…
Post-IPO Equity ·
$600M
P
Portland, United States · Energy
Post-IPO Equity ·
$375M
R
Salt Lake City, United States · Artificial Intelligence (AI)
Post-IPO Equity ·
$150M
T
Rancho Cordova, United States · Biotechnology
Post-IPO Equity ·
$2.1M
L
Hamilton, United States · Agriculture and Farming
Local Bounti is an agriculture company delivering herbs, vegetables, and other produce to service wholesale…
Post-IPO Equity ·
$23M
S
New York, United States · Design
Soluna focuses on creating environmentally-friendly data centers for batch computing that utilize excess…
Post-IPO Equity ·
$2.0M
T
Dallas, United States · Biotechnology
Taysha Gene Therapies is dedicated to eliminating serious and life-threatening genetic diseases in the…
Post-IPO Equity ·
$50M
S
Santa Barbara, United States · Community and Lifestyle
Post-IPO Equity ·
$13M
B
New Haven, United States · Biotechnology
Post-IPO Equity ·
$302M
V
Vertiv
Columbus, United States · Hardware
Post-IPO Equity ·
Undisclosed
D
San Francisco, United States · Biotechnology
Post-IPO Equity ·
$275M
C
Colgate Palmolive
New York, United States · Consumer Goods
Post-IPO Equity ·
Undisclosed
S
Salesforce
San Francisco, United States · Data and Analytics
Post-IPO Equity ·
Undisclosed
S
Sunnyvale, United States · Health Care
Post-IPO Equity ·
$100M
C
Denver, United States · Biotechnology
Post-IPO Equity ·
$4.2M
D
San Francisco, United States · Biotechnology
Post-IPO Equity ·
$345M
C
Los Angeles, United States · Biotechnology
Post-IPO Equity ·
$3.1M
A
Cambridge, United States · Biotechnology
Post-IPO Equity ·
$34M
B
Minneapolis, United States · Financial Services
Post-IPO Equity ·
$175M
J
Santa Cruz, United States · Science and Engineering
Post-IPO Equity ·
$60M
D
Reno, United States · Energy
Dragonfly Energy is an innovation organization situated in Reno, Nevada, on the shores of the delightful…
Post-IPO Equity ·
$150M
I
New York, United States · Biotechnology
Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies…
Post-IPO Equity ·
$60M
B
Burlington, United States · Biotechnology
Bone Biologics, a company headquartered in Burlington, MA, is publicly traded and specializes in the…
Post-IPO Equity ·
$5.1M
I
Cambridge, United States · Biotechnology
Post-IPO Equity ·
$9.0M
A
Cambridge, United States · Biotechnology
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.…
Post-IPO Equity ·
$246M
F
Brooklyn, United States · Biotechnology
First Wave BioPharma is a biopharmaceutical company at the clinical stage that focuses on creating targeted…
Post-IPO Equity ·
$6.0M
I
New York, United States · Biotechnology
Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with…
Post-IPO Equity ·
$75M
R
Cranbury, United States · Biotechnology
Post-IPO Equity ·
$100M
A
Austin, United States · Biotechnology
Anebulo is a clinical-stage biotechnology company developing novel solutions for people suffering from…
Post-IPO Equity ·
$6.6M
G
Chicago, United States · Financial Services
GoHealth is the nation’s most complete online portal for finding health insurance coverage. They’ve helped…
Post-IPO Equity ·
$50M
S
Laguna Hills, United States · Biotechnology
Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The…
Post-IPO Equity ·
$63M
A
Pacific Palisades, United States · Biotechnology
Aadi Bioscience, Inc. is a biopharmaceutical company developing precision therapies for genetically-defined…
Post-IPO Equity ·
$73M
F
Secaucus, United States · Community and Lifestyle
Freshpet is makes fresh and all natural refrigerated dog and cat food in the U.S., and the is fastest growing…
Post-IPO Equity ·
Undisclosed
P
Redwood City, United States · Food and Beverage
Presto overlays next-gen digital solutions onto the physical world. Presto’s enterprise-grade voice, vision,…
Post-IPO Equity ·
$70M
S
Cambridge, United States · Biotechnology
Spero Therapeutics is developing first in class therapeutics for treatment of Gram-negative infections. The…
Post-IPO Equity ·
$9.0M
A
Seattle, United States · Biotechnology
Alpine Immune Sciences is an immunotherapy startup focused on developing recombinant, protein-based…
Post-IPO Equity ·
$100M
I
California, United States · Financial Services
International Land Alliance was formed to develop & sell residential communities for home buyers, investors,…
Post-IPO Equity ·
$5.0M
K
Clearwater, United States · Consumer Electronics
KnowBe4 is a platform for security awareness training and simulated phishing attacks. KnowBe4 enables you to…
Post-IPO Equity ·
$4.2B
P
Austin, United States · Information Technology
Perficient is an information technology consulting firm. Perficient helps clients use Internet-based…
Post-IPO Equity ·
$4.3M
Q
Sunnyvale, United States · Consumer Electronics
QuickLogic Corporation (NASDAQ: QUIK) is the inventor and pioneer of innovative, customizable semiconductor…
Post-IPO Equity ·
$3.2M
T
Oceanside, United States · Biotechnology
Therapeutic Solutions International is a biotechnology company engaged in the development of products for…
Post-IPO Equity ·
$10M
C
Fort Lee, United States · Community and Lifestyle
Creatd is the parent company and creator of the Vocal platform. The Company creates technology-based…
Post-IPO Equity ·
$800k
V
Alpharetta, United States · Apps
Virios Therapeutics is a biopharmaceutical company in the clinical stage that is working on developing new…
Post-IPO Equity ·
$5.0M
A
Loma Linda, United States · Biotechnology
Aditx Therapeutics is a biotechnology company developing a novel nucleic acid-based technology to selectively…
Post-IPO Equity ·
$20M
A
Sunnyvale, United States · Energy
Amprius's silicon anode technology was originally developed at Stanford University and enables dramatic…
Post-IPO Equity ·
$200M
G
Chicago, United States · Hardware
Gogo is an inflight internet company that provides broadband connectivity products and services for aviation.…
Post-IPO Equity ·
$18M
K
Seattle, United States · Consumer Electronics
Know Labs is a non-invasive diagnostic technology platform that uses radio waves to identify and measure…
Post-IPO Equity ·
$7.2M
A
Cambridge, United States · Biotechnology
Akero Therapeutics is dedicated to providing effective treatment options for individuals suffering from…
Post-IPO Equity ·
$200M
C
Overland Park, United States · Agriculture and Farming
At Compass Minerals, we recognize the finite availability of the essential minerals that we provide and are…
Post-IPO Equity ·
$252M
I
South San Francisco, United States · Biotechnology
IDEAYA Biosciences (IDEAYA) is an oncology-focused biotechnology company committed to the discovery of…
Post-IPO Equity ·
$80M
L
Bala Cynwyd, United States · Biotechnology
Larimar Therapeutics, Inc. is a biotechnology company in the clinical stage that is dedicated to creating…
Post-IPO Equity ·
$70M
S
Cambridge, United States · Biotechnology
Sarepta Therapeutics is a biopharmaceutical company that focuses on the discovery and development of…
Post-IPO Equity ·
$6.0M
E
Boulder, United States · Biotechnology
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and…
Post-IPO Equity ·
$138M
B
Hayward, United States · Biotechnology
Benitec Biopharma is using patented ‘gene-silencing’ technology to develop drugs for chronic and…
Post-IPO Equity ·
$18M
C
San Francisco, United States · Biotechnology
Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based…
Post-IPO Equity ·
$20M
R
Cambridge, United States · Biotechnology
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational…
Post-IPO Equity ·
$300M
S
New City, United States · Commerce and Shopping
Splitit is a payment method solution enabling customers to pay for purchases with an existing debit or credit…
Post-IPO Equity ·
$11M
I
Charlotte, United States · Natural Resources
Iperionx are into developing of zero carbon, sustainable critical mineral supply chains.
Post-IPO Equity ·
$16M
T
Atlanta, United States · Artificial Intelligence (AI)
Trust Stamp applies advanced cryptographic techniques and AI-powered presentation-attack detection tools to…
Post-IPO Equity ·
$1.5M
N
Emeryville, United States · Biotechnology
Going Beyond Antibiotics® Developing Anti-Infective Compounds Effective Against Bacteria, Viruses and Fungi.…
Post-IPO Equity ·
$5.3M
S
Stamford, United States · Biotechnology
SpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to…
Post-IPO Equity ·
$225M
4
Phoenix, United States · Community and Lifestyle
4Front is a cannabis company that has positioned itself for long-term success by leveraging its proven…
Post-IPO Equity ·
$2.1M
G
Long Beach, United States · Community and Lifestyle
Glass House Brands Inc. is one of the fastest-growing, vertically integrated cannabis and hemp companies in…
Post-IPO Equity ·
$37M
X
Belgrade, United States · Health Care
Xtant Medical, a medical company, manufactures, markets, and develops regenerative medicine products and…
Post-IPO Equity ·
$9.8M
A
Denver, United States · Health Care
Assure Neuromonitoring is a medical practice company committed to delivering the highest quality service in…
Post-IPO Equity ·
$6.2M
W
Fairfax, United States · Administrative Services
Information Analysis is a provider of IT products and services to the private sector, and federal, state, and…
Post-IPO Equity ·
$1.9M
C
Chatsworth, United States · Consumer Electronics
Capstone Turbine Corporation (Capstone) develops, manufactures, markets and services microturbine technology…
Post-IPO Equity ·
$8.0M
K
Cambridge, United States · Biotechnology
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.…
Post-IPO Equity ·
$150M
R
Lexington, United States · Consumer Electronics
Rubicon is a software platform that provides smart waste and recycling solutions for businesses and…
Post-IPO Equity ·
$111M
A
Cleveland, United States · Biotechnology
A clinical-stage biopharmaceutical business called Athersys has a growing pipeline of potentially…
Post-IPO Equity ·
$12M
C
C4 Therapeutics
Cambridge, United States · Health Care
C4 is building on the knowledge with synthetic chemical compounds which it calls Degronimids. These compounds…
Post-IPO Equity ·
Undisclosed
F
Frequency Therapeutics
Woburn, United States · Biotechnology
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to…
Post-IPO Equity ·
Undisclosed
F
Cambridge, United States · Biotechnology
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare…
Post-IPO Equity ·
$75M
H
Handa Pharmaceuticals
Fremont, United States · Biotechnology
Handa Pharmaceuticals, LLC (“Handa”) is a specialty pharmaceutical company established in the San Francisco…
Post-IPO Equity ·
Undisclosed
A
Davis, United States · Agriculture and Farming
Arcadia Biosciences is an agricultural technology company focused on developing products that benefit the…
Post-IPO Equity ·
$5.0M
G
Medford, United States · Agriculture and Farming
GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform to deliver…
Post-IPO Equity ·
$109M
P
Carlsbad, United States · Biotechnology
Palisade Bio is a biopharmaceutical company in the clinical stage that focuses on creating treatments for…
Post-IPO Equity ·
$14M
C
Cincinnati, United States · Biotechnology
CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates…
Post-IPO Equity ·
$225M
I
New York, United States · Biotechnology
IN8bio is a clinical-stage biopharmaceutical company focused on the discovery, development and…
Post-IPO Equity ·
$10M
K
Boston, United States · Biotechnology
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative…
Post-IPO Equity ·
$750M
O
Warsaw, United States · Biotechnology
OrthoPediactrics is a medical device company that develops and manufactures orthopedic implants and…
Post-IPO Equity ·
$125M
H
Redwood City, United States · Biotechnology
Heron Therapeutics is a specialized pharmaceutical company creating drug products with the help of its…
Post-IPO Equity ·
$77M
M
San Diego, United States · Biotechnology
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of…
Post-IPO Equity ·
$92M
P
New York, United States · Financial Services
PennantPark Investment Corporation is a publicly traded business development company that specializes in…
Post-IPO Equity ·
$50M
H
Newtown, United States · Biotechnology
Helius Medical Technologies is a company specializing in neurotechnology that aims to enhance neurological…
Post-IPO Equity ·
$18M
A
Stony Brook, United States · Biotechnology
Applied DNA Sciences provides DNA solutions designed to provide the highest level of security. From marking…
Post-IPO Equity ·
$12M
P
San Diego, United States · Biotechnology
Poseida Therapeutics is a clinical-stage biopharmaceutical company utilizing genome engineering capabilities…
Post-IPO Equity ·
$70M
A
Irvine, United States · Health Care
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The…
Post-IPO Equity ·
$112M
A
Burlingame, United States · Biotechnology
Apexigen is a biopharmaceutical product development company advancing a pipeline of novel product candidates…
Post-IPO Equity ·
$15M
C
Boca Raton, United States · Other
Celsius Holdings is a company based in United States.
Post-IPO Equity ·
$550M
F
Durham, United States · Biotechnology
Fennec Pharmaceuticals Inc. (TSX: FRX, OTC: Interim ADHXD, Final FENCF (October 2, 2014), is a clinical-stage…
Post-IPO Equity ·
$45M
T
King Of Prussia, United States · Biotechnology
Trevena is a privately owned biopharmaceutical company based in King of Prussia, PA, focused on developing…
Post-IPO Equity ·
$2.0M
L
The Woodlands, United States · Biotechnology
Vocabulary Pharmaceuticals, Inc. (previously Lexicon Genetic) a biopharmaceutical organization, centers…
Post-IPO Equity ·
$43M
A
Houston, United States · Biotechnology
AlloVir centers around the advancement of cell treatments and spotlights on reestablishing regular resistance…
Post-IPO Equity ·
$127M
L
Piscataway, United States · Biotechnology
Legend Biotech is a biopharmaceutical organization getting effective developments cell treatment, and…
Post-IPO Equity ·
$250M
I
Culver City, United States · Health Care
The goal of ImmunityBio, Inc. (previously NantKwest, Inc.) is to create cell and immunotherapy treatments…
Post-IPO Equity ·
$11M
K
Salt Lake City, United States · Biotechnology
Kiora is a clinical-stage specialty drug organization creating and commercializing items for treating…
Post-IPO Equity ·
$6.0M
B
Duluth, United States · Consumer Electronics
Boxlight is schooling innovation organization that gives innovation arrangements like advanced signage, study…
Post-IPO Equity ·
$5.0M
O
Miami, United States · Biotechnology
Organicell Regenerative Medicine is an exosome therapeutics organization with an emphasis on growing new…
Post-IPO Equity ·
$4.0M
R
Redwood City, United States · Biotechnology
Revolution Medicines is developing new therapies through an innovative approach that harnesses the complex…
Post-IPO Equity ·
$265M

192 more funded startups

292 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Jul 2022). The full 292-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 292 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Industries with the most funded Post-IPO Equity startups in the United States

Sector counts across all 292 tracked companies in the United States. A company assigned more than one industry is counted in each.

Where are funded Post-IPO Equity startups located in the United States?

Where funded Post-IPO Equity startups in the United States are based, by the city on the company record.

Funded Post-IPO Equity startups in the United States by state

The states with the most funded startups on record.

About the FundedIQ Post-IPO Equity startup funding data in the United States

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 292 funded Post-IPO Equity startups in the United States currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. The most recent round on record for funded Post-IPO Equity startups in the United States is dated Oct 2022.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Post-IPO Equity startups are there in the United States?

FundedIQ tracks 292 funded Post-IPO Equity startups in the United States. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

What industries have the most funded Post-IPO Equity startups in the United States?

Biotechnology has the most, with 154 companies, followed by Consumer Electronics (17), Health Care (15) and Financial Services (11). Sector counts include every company assigned that industry, and a company can carry more than one.

Which cities have the most funded Post-IPO Equity startups in the United States?

New York leads with 23 companies, then Cambridge (15), San Diego (12) and San Francisco (12).

How often is the Post-IPO Equity startup funding data in the United States updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Post-IPO Equity startups in the United States is dated Oct 2022. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.